This article discusses a clinical trial investigating how reducing nicotine in cigarettes affects consumption when alternative nicotine delivery systems are available. It aims to inform policies on tobacco harm reduction.
Understanding these dynamics can help shape effective strategies to decrease tobacco addiction and improve public health outcomes globally.